English

NattoPharma: 3rd Quarter  and YTD September 2016 earnings release

Report this content

Please find attached the 3rdquarter 2016 and YTD September Earnings Release.

Highlights for the 3rdquarter and for YTD September 2016;

3rd Quarter 2016

  • Revenue rose by 76 % to NOK 10,8 million
  • Gross Margin for the period was 30,5 %
  • Adj. EBITDA coming in at NOK -4,5 million
  • Loss before tax was NOK -9,5 million

YTD September 2016

  • Revenue rose by 77 % to NOK 36,6 million
  • Gross Margin for the period was 44,5 %
  • Adj. EBITDA coming in at NOK -6,7 million
  • Loss before tax was NOK -19,3 million

A presentation will be held via webcast by CEO Daniel H. Rosenbaum and CFO Kjetil Ramsøy at 10 am CET, Wednesday 16thNovember, followed by a Q&A session directly thereafter.

Please follow the below link to join the webcast;

http://webtv.hegnar.no/presentation.php?webcastId=40093002  



For more information, please contact:

Kjetil Ramsøy

CFO, NattoPharma

E-mail: kjetil.ramsoy@nattopharma.com



This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Tags:

Vitamin K2 NattoPharma MenaQ7 2016 Quarterly Report

Documents & Links